Reset Setting Change contrast to brightChange contrast to originalChange contrast to darkChange font size to lower sizeChange font size to original sizeChange font size to large size
    T
    T
    T
    T
    T
    T

Selamat Datang Ke Portal Rasmi Kementerian Kesihatan Malaysia

DataTerbuka

Broadcast
Pengenalan Kami
Berita
Soalan Lazim
Publication
Pekeliling
OpenData
Hubungi Kami
 
 

bm en

Print
Tajuk Update On Avian Influenza A (H7N9) In China 28 April 2013
Penerangan

 

UPDATE ON

AVIAN INFLUENZA A (H7N9) IN CHINA

 28 APRIL 2013

 

 

Affected places:

 

Seven (7) Provinces: Anhui, Fujian, Henan, Jiangsu, Jiangxi, Shandong and Zhejiang

Two (2) Municipalities: Shanghai and Beijing

 

Number of cases:

 

Two new provinces reported cases of avian influenza A (H7N9) virus: Fujian and Jiangxi.

 

To date, there are a total of 119 laboratory confirmed human cases with avian influenza A (H7N9) virus including 23 fatalities in China reported from seven (7) Provinces: Anhui 4 (1), Fujian 1 (0), Henan 4 (0), Jiangsu 26 (4), Jiangxi 2 (0), Shandong 1 (0) and Zhejiang 45 (6) and two (2) Municipalities: Beijing 1 (0) and Shanghai 34 (12), and 1 (0) Taiwan case. Currently, 80 patients are hospitalized and 16 have been discharged.

 

WHO does not advise special screening at points of entry with regard to this event, nor does it recommend that any travel or trade restrictions be applied.

 

Symptoms:

 

Symptoms include fever, cough, and shortness of breath. Infection with avian influenza A(H7N9) virus has resulted in severe respiratory illness.

 

Source and Mode of Transmission Avian Influenza A (H7N9):

 

Both the source of infection and the mode of transmission are uncertain. The Chinese health authorities are still investigating and heightened disease surveillance. So far, there is no evidence of ongoing human-to-human transmission.

 

Vaccine for Avian Influenza A (H7N9) virus:

 

No vaccine for the prevention of avian influenza A (H7N9) virus infections is currently available. The virus H7N9 is susceptible to

Neuraminidase Inhibitors (OSELTAMIVIR & ZANAMIVIR).

 

Travel advice to China and Taiwan:

 

There is no recommendation against travel to China and Taiwan at this time by WHO. 

 

 

BAHAGIAN KAWALAN PENYAKIT

KEMENTERIAN KESIHATAN MALAYSIA

28 April 2013

Ditambah pada 27-04-2013 04:00:00